# Morgenthaler Ventures' Biotech Investments: 14 Startups in Its Portfolio (2026) > The 14 Biotech startups Morgenthaler Ventures has backed, by stage: $1.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/morgenthaler-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 7 - [SetPoint Medical](https://millionrounds.com/company/setpoint-medical) - [Moximed](https://millionrounds.com/company/moximed) - [*OB* OptiScan Biomedical](https://millionrounds.com/company/optiscan-biomedical) - [Elcelyx Therapeutics](https://millionrounds.com/company/elcelyx-therapeutics) - [Calithera Biosciences](https://millionrounds.com/company/calithera-biosciences) - [NanoOpto](https://millionrounds.com/company/nanoopto) - [*L* Lumend](https://millionrounds.com/company/lumend) ## Stage not reported 5 - [Nuvaira](https://millionrounds.com/company/nuvaira) - [*V* VertiFlex](https://millionrounds.com/company/vertiflex) - [Principia BioPharma](https://millionrounds.com/company/principia-biopharma) - [*FL* ForSight Labs](https://millionrounds.com/company/forsight-labs) - [Mosaic Biosciences](https://millionrounds.com/company/mosaic-biosciences) ## Series B 2 - [Ra Pharmaceuticals](https://millionrounds.com/company/ra-pharmaceuticals) - [Scioderm](https://millionrounds.com/company/scioderm) ## Segment by segment ### Series C and later 7 startups · $801M raised - [**SetPoint Medical**](https://millionrounds.com/company/setpoint-medical) SetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies f United States $256M - [**Moximed**](https://millionrounds.com/company/moximed) Moximed Inc. United States $146M - [*OB* **OptiScan Biomedical**](https://millionrounds.com/company/optiscan-biomedical) United States $121M - [**Elcelyx Therapeutics**](https://millionrounds.com/company/elcelyx-therapeutics) Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders. United States $117M - [**Calithera Biosciences**](https://millionrounds.com/company/calithera-biosciences) Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer. United States $115M - [**NanoOpto**](https://millionrounds.com/company/nanoopto) NanoOpto employs nano-optics and nano-manufacturing technologies to develop components for optical systems and networks. United States $24M - [*L* **Lumend**](https://millionrounds.com/company/lumend) Lumend is a Health Care company. - $23M ### Stage not reported 5 startups · $382M raised - [**Nuvaira**](https://millionrounds.com/company/nuvaira) Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. United States $115M - [*V* **VertiFlex**](https://millionrounds.com/company/vertiflex) United States $107M - [**Principia BioPharma**](https://millionrounds.com/company/principia-biopharma) Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology. United States $90M - [*FL* **ForSight Labs**](https://millionrounds.com/company/forsight-labs) ForSight Labs focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. United States $67M - [**Mosaic Biosciences**](https://millionrounds.com/company/mosaic-biosciences) Mosaic Biosciences is a biotechnology research company based in Boulder, Colorado, founded in 2009. United States $3.3M ### Series B 2 startups · $114M raised - [**Ra Pharmaceuticals**](https://millionrounds.com/company/ra-pharmaceuticals) Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules. United States $77M - [**Scioderm**](https://millionrounds.com/company/scioderm) Scioderm, a clinical stage pharmaceutical company, develops topical products for the treatment of chronic skin diseases. United States $37M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Morgenthaler Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Morgenthaler Ventures** 44 co-investors](https://millionrounds.com/portfolio-maps/morgenthaler-co-investors)[Portfolio map **Morgenthaler Ventures portfolio map** 35 startups · $3.8B](https://millionrounds.com/portfolio-maps/morgenthaler-portfolio-map)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio) ## Raising from investors like Morgenthaler Ventures? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)